Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.110
-0.030 (-2.63%)
Oct 30, 2026, 10:24 AM EDT - Market open
Vivani Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
42
Market Cap
100.13M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 3.38M | -3.52M | -51.00% |
| Dec 31, 2018 | 6.90M | -1.07M | -13.41% |
| Dec 31, 2017 | 7.96M | 3.98M | 99.85% |
| Dec 31, 2016 | 3.99M | -4.97M | -55.47% |
| Dec 31, 2015 | 8.95M | 5.55M | 163.39% |
| Dec 31, 2014 | 3.40M | 1.83M | 117.12% |
| Dec 31, 2013 | 1.57M | 197.78K | 14.47% |
| Dec 31, 2012 | 1.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
VANI News
- 7 weeks ago - Vivani Medical Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 1 month ago - Vivani Medical Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Vivani Medical Slides: Investor presentation - Filings
- 2 months ago - Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Vivani Medical Quarterly report: Q2 2026 - Filings
- 2 months ago - Vivani Medical Earnings release: Q2 2026 - Filings
- 2 months ago - Vivani Medical announces full enrollment, initial dosing in SLIM-1 trial - TheFly
- 2 months ago - Vivani Medical Announces Successful Dosing of All Participants in SLIM-1, a Phase 1 Trial Evaluating NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - GlobeNewsWire